Harvard Bioscience Market Cap 2012-2026 | HBIO

Harvard Bioscience market cap history and chart from 2012 to 2026. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Harvard Bioscience market cap as of June 08, 2026 is $0.02B.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.019B $0.087B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $5.722B 20.54
Kewaunee Scientific (KEQU) United States $0.100B 8.24